Literature review · Skin & hair

AHK-Cu

The directly checked hair-growth evidence is an experiment with isolated human follicles and cultured cells. Human tissue in a laboratory is not a clinical hair-restoration trial.

By HeartPep · Reviewed · 2 selected source records

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

At a glance

One directly relevant hair-follicle study is included, alongside an identity cross-check explaining why a superficially similar Tripeptide-3 paper is not AHK-Cu evidence.

Identity & scope

The cited paper examines the copper complex of alanyl-histidyl-lysine. AHK-Cu and GHK-Cu are distinct sequences; their findings should not be substituted.

Catalogue labels covered: AHK-Cu.

What the research shows

  • Follicle elongation and dermal-papilla-cell proliferation increased under the experimental conditions; the measured reduction in apoptotic cells was not statistically significant.

Critical interpretation

Human tissue does not make this a treatment trial

The follicle experiment supports a local biological hypothesis. It cannot show that a product crosses a scalp or nasal barrier, reaches a comparable exposure or changes a person's hair growth over time. A follow-up clinical study would need a characterised formulation, an appropriate vehicle comparison and objective hair outcomes, rather than counting a cultured follicle as a treated participant. [1]

A naming collision can create false clinical evidence

Tripeptide-3 is not a sufficient identity match. The 2024 emulsion paper specifies dipeptide diaminobutyroyl benzylamide diacetate in its materials section. That chemical identity differs from the copper-bound alanyl-histidyl-lysine in the follicle study. The paper is retained here as a cross-check, not as evidence that AHK-Cu controls facial oil or has been clinically validated. This distinction demonstrates why sequence, chemical identifiers and metal binding matter more than a shared marketing shorthand when selecting references. [1] [2]

Keep excluded material visible

Recording the identity mismatch is useful even though the paper is not support for AHK-Cu. It lets another reader reproduce the exclusion and prevents an appealing clinical result from entering a bibliography through a name match alone. More references would not improve this review if they tested another chemical. [2]

Limitations & uncertainties

  • Isolated follicles do not reproduce long-term scalp exposure, formulation delivery or clinical hair counts.

Open research questions

  • Would a characterised formulation produce a durable, independently replicated benefit in a controlled human trial?

Selected papers & source records

Download bibliography
Cells / laboratoryNamed compoundAbstract / record checked

1. The effect of tripeptide-copper complex on human hair growth in vitro (opens in a new tab)

Pyo HK, Yoo HG, Won CH, et al. (2007). Archives of Pharmacal Research. DOI: 10.1007/BF02978833 (opens in a new tab) · PMID 17703734

Design & population
Isolated human follicles and cultured dermal papilla cells.
What the study found
Elongation and proliferation signals increased; apoptosis findings were mixed.
Limits on interpretation
No clinical hair-restoration endpoint.
Technical referenceIdentity / technical contextFull text consulted

2. Microemulsions and Nanoemulsions for Topical Delivery of Tripeptide-3: From Design of Experiment to Anti-Sebum Efficacy on Facial Skin (opens in a new tab)

Magrode N, Poomanee W, Kiattisin K, Ampasavate C (2024). Pharmaceutics. DOI: 10.3390/pharmaceutics16040554 (opens in a new tab) · PMID 38675215

Design & population
Identity cross-check of a formulation paper that uses the name Tripeptide-3; this is not an AHK-Cu study.
What the study found
Materials identify dipeptide diaminobutyroyl benzylamide diacetate, CAS823202-99-9, rather than alanyl-histidyl-lysine copper.
Limits on interpretation
Included to prevent misattribution. Its formulation and sebum results are not AHK-Cu efficacy evidence.

Search & review scope

Targeted primary-record search.. Checked 9 November 2026.

One direct AHK-Cu follicle study plus a full-text materials identity cross-check of the 2024 Tripeptide-3 paper.

Not an exhaustive review or proof that no additional AHK-Cu research exists. The identity-only reference is excluded from AHK-Cu human efficacy evidence.

Recorded search terms
  • site.pubmed.ncbi.nlm.nih.gov AHK Cu human clinical hair trial
  • The effect of tripeptide-copper complex on human hair growth in vitro retracted
  • AHK Cu tripeptide-3 microemulsion nanoemulsion Magrode 2024 PubMed
  • Microemulsions and Nanoemulsions Dipeptide 823202

Read the collection’s methods and editorial limits. For formal research, assess and cite the original paper.

Cite this review

HeartPep. AHK-Cu: literature review. HeartPep literature library. Reviewed 9 November 2026. https://heartpep.com/us/research/library/ahk-cu.

HeartPep is the commercial publisher of this secondary summary. It is not a peer-reviewed primary paper. Cite the original studies for their findings.

Buy from HeartPep.com

Laboratory research only. Not for human or veterinary use.

← All reviews and reference notes